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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A153monolayer in standard conditions. Gene expression was assessed using
real time RT-PCR. Sulfated proteoglycan content of micromass cultured
chondrocytes was measured using Alcian blue staining followed by
guanidine extraction and spectrophotometric quantiﬁcation. TRPC6
was speciﬁcally activated using hyp9, a stabilized derivative of the
TRPC6-selective activator hyperforin. Intracellular calcium chelation
was achieved by treating cells with BAPTA-AM. AKT phosphorylation
was analyzed usingWestern blot. Calciummobilization in chondrocytes
was measured using a fura-2 calcium inﬂux assay.
Results: TRPC6 mRNA was detected in wild type murine chondrocytes.
Culture of chondrocytes from TRPC6-/- and CXCR2-/- mice in micro-
mass resulted in signiﬁcantly less sulfated proteoglycan production in
comparison to chondrocytes obtained from wild type littermates.
Chondrocytes lacking either TRPC6 or CXCR2 expressed lower levels of
the chondrocyte differentiation markers SOX9 and type II collagen in
comparison to wild type. Activation of CXCR2 in articular chondrocytes
in vitro resulted in an increase in intracellular calcium mobilization. In
vitro activation of TRPC6 using hyp9 led to an increase in AKT phos-
phorylation in wild type chondrocytes, whereas chelation of intra-
cellular calcium inhibited CXCL6 induced phosphorylation of AKT.
Finally, activation of TRPC6 in wild type chondrocytes resulted in a
signiﬁcant increase in SOX9 and type II collagen mRNA expression.
Conclusions: CXCR2 signaling and in particular TRPC6 ion channel
activity is required for chondrocyte phenotypic stability in vitro. TRPC6
mediated calcium mobilization is sufﬁcient to increase AKT phosphor-
ylation and the expression of key chondrocyte molecular markers in
murine chondrocytes, indicating that TRPC6 may be an ideal ther-
apeutic target in the prevention of articular cartilage breakdown during
osteoarthritis.
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THE ACUTE RESPONSE TO JOINT DESTABILISATION IS
DIFFERENTIALLY REGULATED BETWEEN MALE AND FEMALE MICE
C. Driscoll y, F.E. Watt y, F. Dell'Accio z, T.L. Vincent y. y The Kennedy Inst.,
Oxford, United Kingdom; zWilliam Harvey Inst., Queen Mary, University of
London, United Kingdom
Purpose: Gender is known to inﬂuence the severity of osteoarthritis in
mice, with female mice having less cartilage degradation compared
with males. We tested 3 separate hypotheses to account for this dif-
ference: (i) that physical activity levels are lower in female mice, (ii) that
female mice are able to repair cartilage more effectively than male mice
(iii) that female mice respond to acute joint injury (destabilization) with
a different molecular proﬁle. We validated the latter in a cohort of those
with acute destabilising knee injuries.
Methods: The followingmeasures were carried out in 10 week old male
and female mice following destabilization of the medial meniscus
(DMM): Activity levels were measured using LABORAS (laboratory
Animal Behaviour Observation, Registration and Analysis System) 2
weeks following surgery. This allows quantiﬁcation (over a 6h period) of
animal behaviours such as running, climbing, feeding and grooming.
For gene expression studies, mRNA was extracted from whole joints 6h
following surgery and RT-PCR performed for 48 previously validated
genes using Taqman microﬂuidic cards. For investigation of cartilage
repair, 10 week old male and female C57Bl6 mice underwent focal
cartilage injury in the patella groove as previously described (Eltawil et
al, 2009). Joints were scored at 8 weeks for evidence of intrinsic repair.
Human synovial ﬂuid from male and female patients within 8 weeks of
acute knee injury was analysed for selective proteins by Mesoscale
Discovery platform or by plate ELISA.
Results: Activity levels between male and female mice were not sig-
niﬁcantly different (although there was a trend for female mice to be
more active than male mice). In C57 Bl6 mice, there was no evidence of
spontaneous repair of focal full thickness cartilage lesions, irrespective
of gender. When examining the response to acute joint destabilization
there was no difference in the regulation of many inﬂammatory
response genes such as proteases (Adamts4, Adamts5), inﬂammatory
cytokines (IL1b, IL6), chemokines (Ccl2, Ccl7), but 4 genes were con-
sistently higher in female versus male joints. These were Timp1, activin
bA, versican and Mmp3. Of the genes tested in human synovial ﬂuid
samples, activin bA protein levels were signiﬁcantly higher in female
patients compared with male patients post injury.
Conclusions: These results suggest that the initial injury response in
female mice and, to some extent, in humans is different to the response
in males. Genes that were signiﬁcantly higher in female mice includedTimp1 and activin bA (a TGFb family member), which are strongly
FGF2-dependent genes in vivo and have predicted chondroprotective
roles. The mechanism by which these genes may be protective is being
investigated.
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SYNDECAN-4 REGULATES CHONDROCYTE EXTRACELLULAR MATRIX
ARCHITECTURE AND MODULATES WNT3A-INDUCED MATRIX
REMODELING
C.K. Clarke y, U. Hansen y, R. Stange y, F. Echtermeyer z, F. Dell’Accio x,
T. Pap y, J. Bertrand y. y Inst. of Experimental Musculoskeletal Med.,
Muenster, Germany; z Translational Perioperative Inﬂammation Res.,
Med. Sch. Hannover, Hannover, Germany; xWilliam Harvey Res. Inst.,
Ctr. for Experimental Med. and Rheumatology, London, United Kingdom
Purpose: Syndecan-4 (Sdc4), a family member of type I transmembrane
heparan sulfate proteoglycans (HSPGs), is involved in various cartilage-
related processes including osteoarthritis (OA). Blockade of Sdc4 sig-
naling protects mice from cartilage degradation in experimentally
induced OA. OA is characterized by hypertrophic differentiation of
chondrocytes and extracellular matrix (ECM) remodeling, which may
be at least partially triggered by the WNT signaling pathway. Our
experiments emphasize the cross-talk of Sdc4 and WNT signaling and
its inﬂuence on chondrocyte matrix production and remodeling.
Methods: In vitro analyses were performed using neonatal wild type
(wt) and Sdc4-/- chondrocytes. The inﬂuence of WNT3a on glyco-
saminoglycan (GAG) productionwas analyzed using alcian blue staining
of micromass cultures. Expression of marker genes (e.g. aggrecan, col-
lagen2, MMP13) was measured by quantitative RT-PCR. Fibril structure
and remodeling of the matrix upon WNT3a stimulation (with high
concentrations resembling activation of canonical and low concen-
trations promoting non-canonical WNT signaling) was monitored by
electron microscopy using micromass cultures. In vivo relevance was
investigated upon induction of OA using the DMM model.
Results:Micromass cultures revealed a higher basal GAG production by
Sdc4-/- chondrocytes. WNT3a stimulation led to a decrease in GAG
production in wt cells, which was absent in Sdc4-/- chondrocytes. qRT-
PCR showed a 10x higher basal production of aggrecan and collagen2 in
Sdc4-/- chondrocytes. WNT3a increased the expression of both genes in
Sdc-4-/-, whereas it decreased the expression in wt chondrocytes.
MMP13 was signiﬁcantly less expressed in Sdc4-/- chondrocytes and,
unlike in wt cells, was not upregulated upon WNT3a stimulation.
Sdc4-/- cartilage displayed ﬁner, more interspaced and less-orientated
ﬁbril structures compared to wt cartilage. Using micromasses, in wt we
found an increase in ﬁbril production with canonical and on the other
hand a decrease in non-canonical WNT signaling, whereas in Sdc4-/-
micromasses, the ﬁbril production was hardly inﬂuenced. Furthermore,
our results indicate that non-canonical WNT signaling induces ﬁbril
orientation. In vivo studies conﬁrmed in vitro results.
Conclusions: Sdc4 inﬂuences ﬁbril architecture, condensation and
orientation as well as proteoglycan production of the chondrocyte ECM.
Furthermore, Sdc4 cross-talks with the canonical WNT signaling path-
way in regulating matrix remodeling.
We hypothesize that the restructured matrix in Sdc4-deﬁcient cartilage
contributes towards the protection from OA-induced changes by
modulating the response to WNT signaling.
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HYPOXIA-INDUCIBLE FACTOR 3-ALPHA EXPRESSION (HIF-3a) IS
ASSOCIATED WITH THE STABLE CHONDROCYTE PHENOTYPE AND
INHIBITS HIF-2a/ARNTL-MEDIATED TRANSACTIVATION OF MATRIX
METALLOPROTEINASE-13
B.D. Markway y, H. Cho y, D.E. Anderson y, J. Zilberman-Rudenko y,
P. Holden y, A. McAlinden z, M. Otero x, M.B. Goldring x, B. Johnstone y.
yOregon Hlth.& Sci. Univ., Portland, OR, USA; zWashington Univ., St.
Louis, MO, USA; xHosp. for Special Surgery and Weill Cornell Med. Coll.,
New York, NY, USA
Purpose: Hypoxia-inducible factor 2a (HIF-2a) is a potent trans-
activator of the hypertrophy-related genes, MMP13, COL10A1, and
VEGFA; particularly when dimerized with the b-subunit, aryl hydro-
carbon receptor nuclear translocator-like (ARNTL). However, when
redifferentiating chondrocytes are subjected to a hypoxic environment
wherein HIF-2a is stabilized, we do not observe upregulation of MMP13
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A154and COL10A1; instead these genes are downregulated by hypoxia.
Another hypoxia-inducible factor isoform, HIF-3a, is reportedly able to
bind HIF-1a, HIF-2a, and HIF-1b (ARNT) and may inhibit their tran-
scriptional activity. Unlike HIF-1a and HIF-2a, very little is known about
the expression and function of HIF-3a in the context of chondrocyte
biology, but knockdown studies in osteosarcoma cells have implicated it
in the regulation of hypertrophy-related genes. We therefore examined
the expression of HIF-3a in chondrogenic cells at various levels of dif-
ferentiation, and tested its contribution to the HIF-2a/ARNTL-driven
transactivation of MMP13.
Methods:HIF-3amRNA (HIF3A) was quantiﬁed in human bonemarrow
mesenchymal stem cells (MSCs) and human primary articular chon-
drocytes from healthy and osteoarthritic (OA) tissue in three-dimen-
sional cultures and in human embryonic epiphyses. The normal and OA
chondrocytes and MSCs were expanded in monolayer and then redif-
ferentiated or differentiated, respectively, in pellet cultures using our
serum-free deﬁned chondrogenic medium containing dexamethasone
and TGF-b1 in hypoxic culture conditions (2% oxygen). For analysis of
HIF3A in tissues, total RNA was extracted via laser capture micro-
dissection from different zones of human embryonic growth plates.
HIF3A mRNA was quantiﬁed in cells and tissues by qPCR using Taqman
primers speciﬁc to a region shared by all known splice variants. Dual-
luciferase assays were performed using the human chondrocyte cell
line, C28/I2. Cells were transfected with pRL-TK Renilla luciferase con-
trol vector, -1602/þ20-MMP13-Luc reporter construct, and expression
vectors for HIF-2a, full-length HIF-3a (i.e. HIF-3a9), and ARNTL alone or
in combination. Transfected cells were lysed after 24 hours and ﬁreﬂy
and Renilla luciferase measured using the Dual-Luciferase Reporter
Assay System (Promega). To assess in vivo binding interactions, HEK293
cells were transiently transfected with expression vectors for ARNTL-
V5-His and HIF-3a alone or in combination and lysed after 48 hours.
Cell extracts were immunoprecipitated with anti-His antibody. SDS-
PAGE separated proteins in the immunoprecipitates were Western
blotted with anti-HIF-3a antibody (Abcam).
Results: HIF3A expression was very low in dedifferentiated healthy
human chondrocytes but signiﬁcantly increased during rediffer-
entiation (>1000-fold). By comparison, HIF3A was expressed at sig-
niﬁcantly lower levels in chondrocytes from OA joints, expressing
higher levels of COL10A1 and MMP13 when compared to healthy
counterparts. Consistent with this, HIF3A was extremely low in both
undifferentiated and chondrogenically-induced MSCs expressing very
high levels of hypertrophic genes. The inverse association of HIF3Awith
hypertrophic markers was conﬁrmed in vivo by analysis of different
zones of human embryonic growth plate cartilage: HIF3A expression
was highest in the zone containing precursor chondrocytes and lowest
in the hypertrophic zone. A functional role related to hypertrophic gene
expression was conﬁrmed by reporter gene assays. As previously
reported, co-expression of HIF-2a alone with an MMP13 reporter was
sufﬁcient to activate transcription; and co-transfection with ARNTL
enhanced HIF-2a-mediated transactivation. Co-transfection of HIF-3a
decreased the reporter activity driven by either HIF-2a alone or the
combination of HIF-2a and ARNTL. Neither HIF-3a alone nor the com-
bination of HIF-3a and ARNTL activated the reporter, indicating that the
reduction in activity caused by HIF-3a is not due simply to its weaker
transcriptional activity. Immunoprecipitation of ARNTL co-precipitated
with HIF-3a, suggesting competition for this b-subunit as a potential
mechanism for HIF-3a inhibition of MMP13 expression.
Conclusions: HIF-3a has an inverse association with hypertrophic
markers in chondrogenic cells in vitro and in vivo, and can inhibit HIF-
2a/ARNTL-mediated transactivation of MMP13. The ﬁndings presented
here lend support to the hypothesis that HIF-3a is a regulator of
chondrocyte hypertrophic terminal differentiation and suggest that it
should be examined as a potential target in cartilage pathologies.
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DIABETES-ACCELERATED CARTILAGE DEGRADATION IN
OSTEOARTHRITIS IS ASSOCIATED WITH DEFECTIVE AUTOPHAGY
M. Ribeiro y,z, P. Lopez de Figueroa y, F.J. Blanco y, A.F. Mendes z,x,
B. Carames y. yCartilage Biology Group, Rheumatology Div., INIBIC-
Complejo Hosp.ario A Coru~na, A Coru~na, Spain; zCtr. for NeuroSci. and
Cell Biology, Univ. of Coimbra, Coimbra, Portugal; x Faculty of Pharmacy,
Univ. of Coimbra, Coimbra, Portugal
Purpose: Type 2 Diabetes (T2D), a disease that causes blood glucose
levels to rise higher than normal and has an impact on insulinutilization, is an important risk factor for Osteoarthritis (OA), the most
prevalent aging-related joint disease that affects millions of people
worldwide. Although epidemiological studies suggest a strong associ-
ation between these diseases, how T2D contributes to the deterioration
of articular cartilage is still unknown. Autophagy is a central homeo-
static mechanism for cellular quality control. Several studies suggest
that autophagy is impaired both in OA and T2D, however, how diabetic
conditions inﬂuence autophagy in articular cartilage remains unex-
plored. The objective of this study is to understand the role of
autophagy in the articular cartilage function under diabetic conditions.
Methods: Human primary articular chondrocytes (HC) and a chon-
drocytic cell line (TC28a2) were cultivated in DMEM high glucose (25
mM glucose) and treated with Insulin (10, 100, 500 nM) for 2, 6 or 24
hours. LC3II levels were evaluated by Western blotting (WB) and
Inmunoﬂuorescence (IF). To explore the molecular mechanism poten-
tially involved in this effect, the phosphorylation status of Akt and the
ribosomal protein S6 (rpS6) was evaluated by WB. To further investigate
whether autophagy activation protects chondrocytes from diabetic
conditions, autophagy was induced by the mammalian target of Rapa-
mycin complex 1 (mTORC1) selective inhibitor, Rapamycin (10 mM).
Furthermore, human cartilage explants were cultivated in DMEM high
glucose and insulin (100, 500, 1000 nM) for 24 hours. Cartilage explants
were evaluated by Safranin O staining andMMP-13 and IL-1b expression
was quantiﬁed by immunohistochemistry (IHC) and WB, respectively.
Expression of LC3 and p-rpS6 was determined by WB in primary human
chondrocytes from Osteoarthritis (OA) and OA-Diabetic patients.
Results: In the presence of high glucose and insulin, autophagy was
decreased in a concentration-dependent-manner in human chon-
drocytes, as indicated by LC3II expression, the main marker of
autophagy activation (TC28-a2; p < 0.05 at 6 hours post-treatment; HC;
p < 0.01 at 24 hours post-treatment compared to untreated condition).
To investigate the mechanism by which autophagy is reduced by
insulin, Akt and rpS6 phosphorylation was analyzed. We observed a
signiﬁcant increase in p-AKT and p-rpS6 levels, suggesting that the
effect of insulin on autophagy is mediated by AKT/mTOR pathway
(TC28-a2 p < 0.05 at 6 hours; HC; p < 0.01 at 2 hours compared to
untreated condition). Furthermore, pharmacological induction of
autophagy by Rapamycin reversed insulin effects on LC3II and p-rbS6
levels (Tc28a2 and HC: p < 0.05 at 24 hours post-treatment), indicating
that autophagy induction prevents insulin-mediated autophagy
downregulation. To evaluate the impact of insulin-mediated autophagy
regulation in the context of articular cartilage biology, cartilage explants
were treated with insulin (100, 500 and 1000 nM) for 24 hours. His-
tological analysis indicated a dramatic loss of proteoglycans after
insulin treatment. The observed cartilage degradation was associated
with an increase in OA pathology biomarkers, MMP-13 and IL-1b
expression (p < 0.01 compared to untreated condition). Remarkably,
cartilage tissue from OA-diabetic patients, showed decreased LC3 and
increased p-rpS6 expression compared to non-diabetic OA patients,
indicating a defect on basal autophagy mechanisms.
Conclusions: Our ﬁndings indicate that diabetic conditions contribute
to impair autophagy in human chondrocytes and cartilage and this is
associated with increased cartilage degradation. Furthermore, diabetic
conditions decreased autophagy in cultured chondrocytes by an AKT/
mTOR-dependent mechanism. Therefore, pharmacological inter-
ventions that activate autophagy by inhibition of mTOR might protect
against T2D-associated OA in human chondrocytes. Our data also
indicate that chondrocytes from OA-diabetic patients exhibit a deﬁcient
basal autophagy. Taking together, these results suggest that impaired
autophagy might be one of the mechanisms by which T2D diabetes
accelerates cartilage degradation.
This study was supported by Instituto de Salud Carlos III- Ministerio de
Economía y Competitividad, Spain-CP11/00095 and Ph.D. Fellowship
SFRH/BD/78188/2011 from FCT Portugal and European Regional
Development Fund through COMPETE
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HSP70 INDUCED BY HIF-1 ALFA REGURATES ANABOLIC RESPONSES
IN CHONDROCYTES UNDER HYPOXIC CONDITIONS
K. Honjo y, Y. Arai y, S. Tsuchida y, S. Nakagawa y, H. Inoue y, M. Saito y,
S. Ichimaru y, S. Shimomura y, A. Inoue y, R. Terauchi y, O. Mazda z,
T. Kubo y. yDept. of Orthopaedics, Graduate Sch. of Med. Sci., Kyoto
Prefectural Univ. of Med., Kyoto, Japan; zDept. of Immunology, Graduate
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